croi-2013-pocket-program

CROI 2013 General Information
OVERVIEW
The 20 th Conference on Retroviruses and Opportunistic Infections (CROI)
is a research meeting created to provide a forum for basic scientists, clinical
investigators, and global health researchers to present, discuss, and critique
their investigations into the epidemiology and biology of human retroviruses
and the diseases they produce with the ultimate goal of translating laboratory
and clinical research into progress against the AIDS epidemic.
To support the goals of the meeting and the preferences of the scientific
community the conference serves, the Scientific Program Committee has
limited registration to researchers actively participating as investigators in
basic science or clinical studies of retroviral diseases and their complications
and clinician-teachers (full-time academic faculty members responsible for
HIV/AIDS training and research programs). Preference will be accorded to
doctoral and professional degree level researchers/clinicians. In addition, a
limited number of slots have been reserved for: 1) media, 2) AIDS treatment
and prevention community educators, and 3) senior clinical development
personnel from industry who have product development planning
responsibilities.
At the conclusion of CROI 2013, attendees will again be polled
to determine their programmatic and logistical preferences for future
conferences. CME Claims and/or Conference Survey should be completed
(online at www.retroconference.org) no later than April 6, 2013. The Scientific
Program Committee welcomes your opinions on how to continue to improve
the conference. The committee will use the survey results to determine the
venue and policies for future meetings, so your feedback is important.
OBJECTIVES
At the completion of this activity, the participants should be able to:
1) appraise and critique their individual efforts in light of the most current
knowledge and information about HIV/AIDS and its complications;
2) integrate into their respective professional medical endeavors those best
practices emerging from laboratory, clinical, and epidemiological research;
and 3) translate the latest laboratory and clinical research into making progress
against the AIDS epidemic.
NEEDS ASSESSMENT
More than 30 million people worldwide are infected with HIV, with
millions of new infections each year. The research efforts of tens of thousands
of scientists and clinicians have had considerable success in diagnosing and
treating infection. Nevertheless, we still do not have either a curative treatment
or a preventive vaccine, without which most of those presently infected will die
of AIDS, and new infections will continue unabated. The need for continued
research on HIV/AIDS is clear. Timely communication of the results of such
research among scientists and clinicians working on this subject is critical to
advancing the field as rapidly as possible. CROI fills this need by bringing
about 4,000 of the leaders in disparate, but interrelated areas of AIDS research
to interact with and educate one another in the very latest results, treatment
methods, and state-of-the-art technological advances.
v